GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » Equity-to-Asset

PreveCeutical Medical (XCNQ:PREV) Equity-to-Asset : -25.82 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PreveCeutical Medical's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-5.40 Mil. PreveCeutical Medical's Total Assets for the quarter that ended in Sep. 2023 was C$0.21 Mil.

The historical rank and industry rank for PreveCeutical Medical's Equity-to-Asset or its related term are showing as below:

XCNQ:PREV' s Equity-to-Asset Range Over the Past 10 Years
Min: -33.04   Med: -4.43   Max: 1
Current: -25.82

During the past 8 years, the highest Equity to Asset Ratio of PreveCeutical Medical was 1.00. The lowest was -33.04. And the median was -4.43.

XCNQ:PREV's Equity-to-Asset is ranked worse than
98.65% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:PREV: -25.82

PreveCeutical Medical Equity-to-Asset Historical Data

The historical data trend for PreveCeutical Medical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical Equity-to-Asset Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial -1.20 -5.23 -11.93 -25.49 -24.52

PreveCeutical Medical Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.65 -30.98 -29.54 -24.52 -25.82

Competitive Comparison of PreveCeutical Medical's Equity-to-Asset

For the Biotechnology subindustry, PreveCeutical Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's Equity-to-Asset falls into.



PreveCeutical Medical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PreveCeutical Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-4.635/0.189
=

PreveCeutical Medical's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-5.396/0.209
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PreveCeutical Medical  (XCNQ:PREV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PreveCeutical Medical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical (XCNQ:PREV) Business Description

Traded in Other Exchanges
Address
885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines